![Tomer Natan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomer Natan
Direttore Finanziario/CFO presso Quark Pharmaceuticals, Inc.
Posizioni attive di Tomer Natan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Direttore Finanziario/CFO | 01/01/2005 | - |
Storia della carriera di Tomer Natan
Formazione di Tomer Natan
Bar-Ilan University | Graduate Degree |
The College of Management Academic Studies | Undergraduate Degree |
Statistiche
Distribuzione geografica
Israele | 3 |
Stati Uniti | 2 |
Posizioni
Director of Finance/CFO | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Tomer Natan
- Esperienza